Literature DB >> 25758761

Accuracy of staging laparoscopy in detecting peritoneal dissemination in patients with gastroesophageal adenocarcinoma.

M Simon1, F Mal1, T Perniceni1, J-M Ferraz1, C Strauss1, H Levard1, C Louvet1, D Fuks1, B Gayet1.   

Abstract

Despite staging laparoscopy (SL) with peritoneal lavage is recommended in US Guidelines in patients with potentially resectable gastroesophageal adenocarcinoma, this procedure is not systematically proposed in French Guidelines. Therefore, we decided to analyze the results of systematic SL in patients considered for preoperative chemotherapy. From 2005 to 2011, 116 consecutive patients with distal esophagus, esogastric junction, and gastric adenocarcinoma ≥T3 or N+ without detectable metastatic dissemination by computed tomography (CT) scan imaging underwent SL before neoadjuvant chemotherapy. Positive and negative SLs were compared according to tumor characteristics. SL was positive in 15 cases (12.9%) including 14 with peritoneal seeding (localized in five, diffuse in nine). SL was positive in 7 (24.1%) of 29 patients with poorly differentiated tumor, in 9 (32.1%) of 28 patients with signet ring cells, in 7 (50%) of 14 patients with gastric linitis tumor, and in 15 (16.3%) of 92 patients with T3 or T4 tumor. All the lesions of distal esophagus extending to the cardia had a negative SL. Among the 14 patients with peritoneal carcinomatosis at SL, nine (65%) had signs of peritoneal seeding on initial CT scan. One (0.8%) patient had a small bowel perforation closed laparoscopically. If systematic SL before preoperative chemotherapy does not seem justified because of its low accuracy, it should be performed in patients with poorly differentiated tumor, signet ring cell, and gastric linitis plastica components on biopsy and when CT scan is suggestive of T4 tumor, ascites, or peritoneal nodule.
© 2015 International Society for Diseases of the Esophagus.

Entities:  

Keywords:  gastroesophageal adenocarcinoma; peritoneal carcinosis; staging laparoscopy

Mesh:

Year:  2015        PMID: 25758761     DOI: 10.1111/dote.12332

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  3 in total

1.  Calculation of a clinical predictive factors identifying peritoneal disease on a staging laparoscopy in gastric cancers.

Authors:  Caleb Harris; Vikas Ostwal; Dilip Harindran Vallathol; Rohit Dusane; Sarika Mandavkar; Shraddha Patkar; Anant Ramaswamy; Shailesh V Shrikhande
Journal:  South Asian J Cancer       Date:  2019 Jul-Sep

2.  Current status and future perspectives on neoadjuvant therapy in gastric cancer.

Authors:  Sheng Ao; Yuchen Wang; Qingzhi Song; Yingjiang Ye; Guoqing Lyu
Journal:  Chin J Cancer Res       Date:  2021-04-30       Impact factor: 5.087

Review 3.  Clinical TNM staging for esophageal, gastric, and colorectal cancers in the era of neoadjuvant therapy: A systematic review of the literature.

Authors:  Hideaki Shimada; Takeo Fukagawa; Yoshio Haga; Shin-Ichi Okazumi; Koji Oba
Journal:  Ann Gastroenterol Surg       Date:  2021-02-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.